NRGN and Alzheimer disease: Recently, the interaction between APO E4 and CSF Ng was investigated in a population of AD and MCI patients, and the authors found higher levels of the protein in MCI carrying APOE e4(+) than APOE e4(−), suggesting an effect of APOE in determining the levels of CSF Ng in the early stages of AD [54].